WST

211.29

0.49% 1.03

Pre-market: 211.00 -0.29 -0.14%

West Pharmaceutical Services Inc (WST)

Overview News Price History Option Chain Financials Why WST Down? Discussions Forecast Stock Split Dividend History

West Pharmaceutical Services Inc stock is traded at $211.29, with a volume of 661.70K. It is up +0.49% in the last 24 hours and down -4.61% over the past month.

Previous Close:

$210.26

Open:

$214.36

24h Volume:

661.70K

Relative Volume:

0.60

Market Cap:

$15.41B

Revenue:

$2.88B

Net Income/Loss:

$499.60M

P/E Ratio:

31.35

EPS:

6.74

Net Cash Flow:

$321.60M

1W Performance:

-1.52%

1M Performance:

-4.61%

6M Performance:

-33.24%

1Y Performance:

-42.66%

1-Day Range:

$209.24

$215.05

1-Week Range:

$206.13

$218.89

52-Week Range:

$187.43

$372.79

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name

West Pharmaceutical Services Inc

Sector

Healthcare (1151)

Industry

Medical Instruments & Supplies (64)

Phone

(610) 594-2900

Address

530 HERMAN O. WEST DRIVE, EXTON, PA

Employee

Twitter

@WestPharma

Next Earnings Date

2024-10-24

Latest SEC Filings

WST's Discussions on Twitter

Compare WST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WST West Pharmaceutical Services Inc	211.29	15.41B	2.88B	499.60M	321.60M	6.74
ISRG Intuitive Surgical Inc	529.42	184.44B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	168.78	58.89B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	98.30	46.96B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	239.95	34.59B	5.02B	1.31B	1.56B	8.91
COO The Cooper Companies, Inc.	82.30	16.16B	3.90B	392.30M	288.10M	1.95

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-18-25	Initiated	Evercore ISI	Outperform
Feb-14-25	Upgrade	Deutsche Bank	Hold → Buy
Jan-08-25	Initiated	Citigroup	Buy
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-12-24	Upgrade	UBS	Neutral → Buy
Feb-07-24	Upgrade	Jefferies	Hold → Buy
Jun-16-23	Upgrade	BofA Securities	Neutral → Buy
Apr-11-23	Upgrade	Stephens	Equal-Weight → Overweight
Dec-14-22	Initiated	Deutsche Bank	Hold
Nov-30-22	Initiated	UBS	Neutral
Oct-28-22	Downgrade	BofA Securities	Buy → Neutral
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Oct-14-20	Initiated	Stephens	Equal-Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Apr-24-20	Upgrade	BofA/Merrill	Underperform → Neutral
Dec-12-19	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-19	Upgrade	BofA/Merrill	Underperform → Neutral
May-01-19	Downgrade	Jefferies	Buy → Hold
Apr-23-19	Initiated	William Blair	Outperform
Apr-25-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-24-18	Initiated	Goldman	Neutral
Oct-17-17	Downgrade	BofA/Merrill	Buy → Neutral
Oct-03-17	Initiated	Stephens	Equal-Weight
Sep-15-17	Upgrade	Jefferies	Hold → Buy
Oct-28-16	Upgrade	Wells Fargo	Market Perform → Outperform
Sep-21-16	Downgrade	Wells Fargo	Outperform → Market Perform
Mar-22-16	Initiated	Wells Fargo	Outperform
May-14-10	Reiterated	UBS	Neutral
Feb-23-10	Initiated	Jefferies & Co	Buy
Dec-19-08	Initiated	UBS	Neutral

View All

West Pharmaceutical Services Inc Stock (WST) Latest News

May 03, 2025

West Pharmaceutical Services: Will Its SmartDose Technology Development Enhance The Business Segment's Competitive Positioning? - Smartkarma

May 03, 2025

May 02, 2025

Is West Pharmaceutical Services, Inc (WST) positioned for future growth? - Sete News

May 02, 2025

West Pharmaceutical Services (WST) Fell on Disappointing Guidance - Insider Monkey

May 02, 2025